| TOVX Stock | | | USD 1.44 0.10 7.46% |
Theriva Biologics financial indicator trend analysis is much more than just breaking down Theriva Biologics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theriva Biologics is a good investment. Please check the relationship between Theriva Biologics Non Current Assets Total and its Long Term Debt accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.
Non Current Assets Total vs Long Term Debt
Non Current Assets Total vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Theriva Biologics Non Current Assets Total account and
Long Term Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Theriva Biologics' Non Current Assets Total and Long Term Debt is -0.81. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Theriva Biologics, assuming nothing else is changed. The correlation between historical values of Theriva Biologics' Non Current Assets Total and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Theriva Biologics are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Non Current Assets Total i.e., Theriva Biologics' Non Current Assets Total and Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.81 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Long Term Debt
Long-term debt is a debt that Theriva Biologics has held for over one year. Long-term debt appears on Theriva Biologics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Theriva Biologics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from Theriva Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theriva Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Theriva Stock please use our
How to Invest in Theriva Biologics guide.At this time, Theriva Biologics'
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 0.75 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.1
M in 2024.
Theriva Biologics fundamental ratios Correlations
Click cells to compare fundamentals
Theriva Biologics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Theriva Biologics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to
measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to
predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.